Characteristic Differences between Patients Who Have Undergone Surgical Treatment for Lung Metastasis or Hepatic Metastasis From Colorectal Cancer

Abstract

Objective: The characteristic differences between patients with lung or liver metastases from colorectal carcinoma (CRC) have not yet been clarified. A small group of these patients demonstrate a better prognosis, and the selection criteria for resection of liver and/or lung metastasis are not well defined. It is important to compare and analyze the most common metastatic sites, which include liver metastases and lung metastases. The objective of this study was to compare the characteristics of the two groups in order to identify patients who benefitted from surgical resection of CRC. Methods: We retrospectively reviewed the medical charts of 80 patients who had undergone resection for liver or lung metastasis from CRC in Fukuoka University Hospital between June 1991 and December 2004. These patients were grouped according to surgical therapy received for the metastases, and separated into two groups, as follows: LUM, lung metastases resection; LIM, liver metastases resection. We evaluated these groups for a set of several factors. Results: The characteristic factors between the two groups (LUM vs. LIM) demonstrated significant differences according to histological differentiation, venous invasion, and lymphatic permeation. There was a statistical difference in the disease-free interval (DFI) between the two groups (947.06 ± 840.39 days in LUM vs. 246.03 ± 229.26 days in LIM). Although serum CEA levels at resection of metastasis showed significant differences between the groups (LUM, 13.25 ± 31.55 ng/ml; LIM, 55.21 ± 99.52 ng/ml), the primary serum CEA levels were not significantly different. Overall survival rates at 5 years were 37.0 % for LUM and 42.8 % for LIM. There was no significant difference in the survival rate of the LUM vs. the LIM group after resection of metastasis. The Cox proportional hazards regression model was used to determine serum CEA status at the time of the metastases and showed a significant difference indicating poor prognosis for patients with LUM, but the results were not significant for LIM cases. Conclusions: Candidates for surgical treatment for lung or liver metastases from CRC may be an acceptable for the same valuable approach, even if characteristic differences were observed in each group.

Metastatic lung tumor - metastatic liver tumor - colorectal cancer (CRC) - prognosis - disease-free interval (DFI)

References

• 1 Welch J P, Donaldson G A. Detection and treatment of recurrent cancer of the colon and rectum.  Am J Surg. 1973;  135 505-511
• 2 Glandiuk S, Wieand H S, Moertel C G, Cha S S, Fitzgibbons R J, Pemberton J A. Pattern of recurrence after curative resection of carcinoma of the colon and rectum.  Surg Gynecol Obstet. 1992;  174 27-32
• 3 Jatzko G R, Lisborg P H, Stettner H M, Klimpfinger M H. Hepatic resection for metastases from colorectal carcinoma: a survival analysis.  Eur J Cancer. 1995;  31 41-46
• 4 Rena O, Casadio C, Viano F, Cristofori R, Ruffini E, Filosso P L, Maggi G. Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience.  Eur J Cardiothorac Surg. 2002;  21 906-912
• 5 Headrick J R, Miller D L, Nagorney D M, Allen M S, Deschamps C, Trastek V F, Pairolero P C. Surgical treatment of hepatic and pulmonary metastases from colon cancer.  Ann Thorac Surg. 2001;  71 975-979
• 6 Landreneau R J, Giacomo T D, Mack M J, Hazelrigg S R, Ferson P F, Keenan R J, Luketich J D, Yim A P, Coloni G F. Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases.  Eur J Cardiothorac Surg. 2000;  18 671-677
• 7 Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Watanabe G. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as prognostic factor.  J Thorac Cardiovasc Surg. 2004;  128 517-522
• 8 Shiono S, Ishii G, Nagai K, Yoshida J, Nishimura M, Murata Y, Tsuta K, Nishiwaki Y, Kodama T, Ochiai A. Histopathologic prognostic factors in resected colorectal lung metastases.  Ann Thorac Surg. 2005;  79 278-283
• 9 Shirakusa T, Tsutsui M, Notonaga R, Ando K, Kusano T. Resection of metastatic lung tumor: the evaluation of histologic appearance in the lung.  The American Surgeon. 1988;  54 655-658
• 10 Ruers T J, Langenhoff B S, Neeleman N, Jager G J, Strijk S, Wobbes T, Corstens F H, Oyen W J. Value of positron emission tomography with (F-18) fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.  J Clin Oncol. 2002;  20 388-395
• 11 Stessels F, Van den Eynden G, Van der Auwera I, Salgado R, Van den Heuvel E, Harris A L, Jackson D G, Colpaert C G, van Marck E A, Dirix L Y, Vermeulen P B. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.  Br J Cancer. 2004;  90 1429-1436
• 12 Zink S, Kayser G, Gabius H J, Kayser K. Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases.  Eur J Cardiothorac Surg. 2001;  19 908-913
• 13 Sakamoto T, Tsubota N, Iwanaga K, Yuki T, Matsuoka H, Yoshimura M. Pulmonary resection for metastases from colorectal cancer.  Chest. 2001;  119 1069-1072
• 14 Sato T, Konishi K, Yabushita K, Nojima N, Kimura H, Maeda K, Tsuji M, Miwa A. The time interval between primary colorectal carcinoma resection to occurrence of liver metastases is the most important factor for hepatic resection. Analysis of total course following primary resection of colorectal cancer.  Int Surg. 1998;  83 340-342
• 15 Finlay I G, Meek D R, Gray H W. Incidence and detection of occult hepatic metastases in colorectal carcinoma.  Br Med J. 1982;  284 803-805
• 16 O'Reilly M S, Boehm T, Shing Y, Fukai N, Vasios G, Lane W S, Flynn E, Birkhead J R, Olsen B R, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.  Cell. 1997;  88 277-285
• 17 Hara Y, Ogata Y, Shirouzu K. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis.  J Exp Clin Cancer Res. 2000;  19 497-504
• 18 Peeters C F, Westphal J R, de Waal R M, Ruiter D J, Wobbes T, Ruers T J. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients.  Int J Cancer. 2004;  112 554-559
• 19 Higashiyama M, Kodama K, Higaki N, Takami K, Murata K, Kameyama M, Yokouchi H. Surgery for pulmonary metastases from colorectal cancer: the importance of prethoracotomy serum carcinoembryonic antigen as an indicator of prognosis.  Jpn J Thorac Cardiovasc Surg. 2003;  51 289-296
• 20 Topal B, Kaufman L, Aerts R, Penninckx F. Patterns of failure following curative resection of colorectal liver metastases.  Eur J Surg Oncol. 2003;  29 248-253
• 21 Jessup J M, Petrick A T, Toth C A, Ford R, Meterissian S, O'Hara C J, Steele Jr G, Thomas P. Carcinoembryonic antigen: enhancement of liver colonisation through resection of human colorectal carcinoma cells.  Br J Cancer. 1993;  67 464-470
• 22 Koshiji M, Ogura E, Takada H, Kawanishi H, Ikehara S, Hioki K. Clinicopathologic and immunohistochemical analyses in lung metastasis of colorectal carcinoma.  Oncol Rep. 1998;  5 811-815
• 23 Ueda K, Iwahashi M, Nakamori M, Nakamura M, Matsuura I, Ojima T, Yamaue H. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.  Surgery. 2003;  133 309-317
• 24 Sawa T, Yoshida T, Ikoma T, Toyoda M, Ohno Y, Fujiwara H. Evaluation of the increasing serum lactate dehydrogenase caused by recombinant human granulocyte-colony stimulating factor.  Gan To Kagaku Ryoho. 2003;  30 51-58
• 25 Patel N A, Keenan R J, Medich D S, Woo Y, Celebrezze J, Santucci T, Maley R, Landreneau R L, Roh M S. The presence of colorectal hepatic metastases does not preclude pulmonary metastasectomy.  Am Surg. 2003;  69 1047-1053